SEAPORT THERAPEUTICS, INC.

Profile

Company Names

SEAPORT THERAPEUTICS, INC.

Addresses

6 TIDE STREET, SUITE 400, BOSTON, MA 02110

Phone Numbers

617-807-4062

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$225,899,940.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-10-18 
$225,899,940.00 
$225,999,937.00 
$99,997.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
CHEN 
EXECUTIVE OFFICER
SUR-SEAL HOLDING, LLC   |  UA SERIES II LLC   |  SEAPORT THERAPEUTICS, INC.   |  GEM REALTY EVERGREEN FUND, L.P.
BHARATT 
 
CHOWRIRA 
DIRECTOR
SYNLOGIC, LLC   |  CRITICAL OUTCOME TECHNOLOGIES INC.   |  AKILI INTERACTIVE LABS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  SEAPORT THERAPEUTICS, INC.
ERIC 
 
ELENKO 
DIRECTOR
GELESIS INC   |  KARUNA PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  AKILI INTERACTIVE LABS, INC.   |  SEAPORT THERAPEUTICS, INC.
LANA 
 
GLADSTEIN 
EXECUTIVE OFFICER
SEAPORT THERAPEUTICS, INC.
ERIC 
 
GREEN 
EXECUTIVE OFFICER
PENN MID CAP EQUITY FUND, L.P.   |  VINEYARD TENACITY OPPORTUNITY FUND, L.P.   |  DUST CUTTER   |  SEAPORT THERAPEUTICS, INC.   |  HRCP REIT, INC.   |  UPWELLING EQUITY INVESTORS II LP   |  HINES RIALTO CREDIT PARTNERS, LP
JAMES 
I. 
HEALY 
DIRECTOR
CEBIX INCOPRATED   |  AMARIN CORP PLC\UK   |  SORBENT THERAPEUTICS INC   |  CEBIX INC   |  HYPERION THERAPEUTICS INC   |  ITERUM THERAPEUTICS LTD   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  SEAPORT THERAPEUTICS, INC.
ANTONY 
 
LOEBEL 
EXECUTIVE OFFICER
SEAPORT THERAPEUTICS, INC.
ROBERT 
 
NELSEN 
DIRECTOR
FORGE INC   |  RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  AGIOS PHARMACEUTICALS INC   |  KILIMANJARO ENERGY, INC.   |  NEUROGESX INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SYROS PHARMACEUTICALS, INC.   |  FATE THERAPEUTICS INC   |  CENEXYS, INC.   |  JUNO THERAPEUTICS, INC.   |  BELLEROPHON THERAPEUTICS LLC   |  FARADAY PHARMACEUTICALS, INC.   |  SAPPHIRE ENERGY, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARIVALE INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  GOSSAMER BIO, INC.   |  VIR BIOTECHNOLOGY, INC.   |  BEAM THERAPEUTICS INC.   |  GRAIL, INC.   |  APEX NEURO HOLDINGS, INC.   |  NUTCRACKER THERAPEUTICS, INC.   |  SANA BIOTECHNOLOGY, INC.   |  INSITRO, INC.   |  NATIONAL RESILIENCE, INC.   |  MEDICAL CREATIONS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  RIPPL CARE, INC.   |  SEAPORT THERAPEUTICS, INC.
STEVEN 
 
PAUL 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SAGE THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  SEAPORT THERAPEUTICS, INC.
JASON 
 
PITTS 
DIRECTOR
SEAPORT THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.
DENICE 
 
TORRES 
DIRECTOR
WYLEI, INC.   |  BLUEBIRD BIO, INC.   |  2SEVENTY BIO, INC.   |  SEAPORT THERAPEUTICS, INC.   |  BYHEART, INC.
DAVID 
 
WHEADON 
DIRECTOR
SEAPORT THERAPEUTICS, INC.
DAPHNE 
 
ZOHAR 
EXECUTIVE OFFICER, DIRECTOR
SATORI PHARMACEUTICALS INC   |  FOLLICA, INC   |  KARUNA PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SEAPORT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#